Stockreport

Lexeo Therapeutics, Inc. (LXEO) Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy Transcript [Seeking Alpha]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF Company Participants Louis Tamayo - CFO & Principal Accounting Officer Eric Adler - Chief Medical Officer & Head of Research Victoria Parikh Conference Call Par [Read more]